CME: Best Practices for Managing Diabetic Retinopathy: Improving Your Care Plans Today

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Best Practices for Managing Diabetic Retinopathy: Improving Your Care Plans Today

Program Information
Best Practices for Managing Diabetic Retinopathy: Improving Your Care Plans Today
How do optometrists identify diabetic retinopathy and/or macular edema in at-risk patients? An expert weighs in.

Available credits: 0.25

Time to complete: 15 Minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • In Partnership with

    • Overview

      As the primary care providers of our patients’ eye health, it’s important for optometrists to be assertive with screening and following patients with diabetes so that they’re appropriately referred when retinopathy and/or macular edema develops. Join Dr. Mark Dunbar as he interviews Dr. Diana Shechtman to uncover best practices for identifying suspected diabetic retinopathy and/or macular edema in at-risk patients.

      Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

    • Disclosure of Conflicts of Interest

      In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

      Mark T. Dunbar, OD, FAAO
      Director of Optometric Services
      Bascom Palmer Eye Institute
      University of Miami
      Miami, FL

      Consulting Fees: Allergan, Genentech, Regeneron Pharmaceutcials, Zeiss

      Diana L. Shechtman, OD, FAAO
      Retina Macula Specialists of Miami
      Miami, FL

      Consulting Fees: Allergan, Regeneron Pharmaceuticals, Zeiss

      Reviewers/Content Planners/Authors:

      • All PIM planners and managers have no conflicts to report.
      • Rob Braun has nothing to disclose.
      • Emily Chew, MD has nothing to disclose.
      • Ann Early has nothing to disclose.
      • Amanda Hilferty has nothing to disclose.
      • William Mencia, MD, FACEHP, CHCP has nothing to disclose. 
      • Robert S. Schneider, MSW has nothing to disclose. 
      • Stephanie Wenick has nothing to disclose.
    • Learning Objectives

      After participating in this educational activity, participants should be better able to:

      • Formulate practice strategies that optimize screening opportunities for identifying suspected DR/DME in patients in at-risk categories for diabetes
    • Target Audience

      This activity is designed to meet the educational needs of optometrists and other eye health professionals.

    • Accreditation and Credit Designation Statements

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and the National Eye Institute of the National Institutes of Health, of the U.S. Department of Health and Human Services. GLC is accredited by the ACCME to provide continuing medical education for physicians.

      Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


      In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Review Group Vision Care Education.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

      This course is COPE approved for 0.25 hours of CE credit. Course ID is 64689-PS. Check with your local state licensing board to see if this counts toward your CE requirement for relicensure.

    • Provider(s)/Educational Partner(s)

      Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

      Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

      This activity is provided in partnership with the National Eye Institute, of the National Institutes of Health, of the US Department of Health and Human Services. The National Eye Health Education Program of the NEI is acknowledged for its important contributions to this initiative.

    • Commercial Support

      This activity is supported by an independent educational grant from Regeneron Pharmaceuticals.

    • Disclaimer

      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

      Reproduction Prohibited

      Reproduction of this material is not permitted without written permission from the copyright owner.

    • System Requirements

      Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

    Facebook Comments

    LIVE ON REACHMD RADIOBack to live radio


    Programs 10/20/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.